Copyright
©The Author(s) 2024.
World J Nephrol. Dec 25, 2024; 13(4): 99643
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.99643
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.99643
Table 3 Comparison of clinicopathologic characteristics of patients with and without relapse in adult minimal change disease (mean ± SD)
| Characteristics | Patients with relapse (n = 4) | Patients without relapse (n = 17) | P value |
| Age (years) | 21.0 ± 2.94 | 26.76 ± 10.65 | 0.30 |
| Males, (%) | 100 | 58.8 | 0.16 |
| Systolic BP (mmHg) | 105.5 ± 9.71 | 123.8 ± 15.4 | 0.03 |
| Diastolic BP (mmHg) | 67.0 ± 6.0 | 81.76 ± 13.09 | 0.04 |
| Serum Albumin (g/dL) | 1.25 ± 0.25 | 2.10 ± 0.96 | 0.05 |
| Serum Cr (mg/dL) | 0.68 ± 0.12 | 0.86 ± 0.25 | 0.18 |
| Urinary proteins (g/day) | 4.52 ± 2.81 | 4.21 ± 2.07 | 0.80 |
| Duration of follow up (months) | 36.5 ± 19.6 | 38.47 ± 23.4 | 0.87 |
| Serum Cr at last follow up (mg/dL) | 0.71 ± 0.55 | 0.83 ± 0.26 | 0.37 |
| Remission at last follow up (%) | 75 | 70.6 | 0.57 |
| Normal renal function at last follow up (%) | 75 | 76.5 | 0.69 |
- Citation: Shakeel S, Rashid R, Jafry NH, Mubarak M. Adult minimal change disease: Clinicopathologic characteristics, treatment response and outcome at a single center in Pakistan. World J Nephrol 2024; 13(4): 99643
- URL: https://www.wjgnet.com/2220-6124/full/v13/i4/99643.htm
- DOI: https://dx.doi.org/10.5527/wjn.v13.i4.99643